JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
Community Trust Bancorp
CTBI
$1.38B
| $3.25M | ﹤0.01% |
85,485
-50,049
| -37% | -$2.13M |
2013 Q2
39 quarters
|
|
3027
White Mountains Insurance
WTM
$4.86B
| $3.25M | ﹤0.01% |
2,356
+1,093
| +87% | +$1.57M |
2017 Q4
21 quarters
|
|
3028
Sotera Health
SHC
$5.21B
| $3.23M | ﹤0.01% |
180,569
+22,113
| +14% | +$369K |
2020 Q4
9 quarters
|
|
3029
Blue Owl Capital
OWL
$6.2B
| $3.23M | ﹤0.01% |
291,866
-164,938
| -36% | -$1.98M |
2021 Q4
5 quarters
|
|
3030
Origin Bancorp
OBK
$1.63B
| $3.23M | ﹤0.01% |
100,417
-41,564
| -29% | -$1.53M |
2018 Q2
19 quarters
|
|
3031
PUT
Allstate
ALL
$56.7B
| $3.23M | ﹤0.01% |
29,100
-3,000
| -9% | -$379K |
2022 Q1
4 quarters
|
|
3032
PRA Group
PRAA
$754M
| $3.23M | ﹤0.01% |
82,776
+41,575
| +101% | +$1.63M |
2013 Q2
39 quarters
|
|
3033
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$696M
| $3.22M | ﹤0.01% |
58,023
+57,682
| +16,916% | +$3.19M |
2022 Q4
1 quarter
|
|
3034
Viper Energy
VNOM
$8.09B
| $3.22M | ﹤0.01% |
115,133
+80,632
| +234% | +$2.42M |
2016 Q2
27 quarters
|
|
3035
Stock Yards Bancorp
SYBT
$2.39B
| $3.22M | ﹤0.01% |
58,391
+5,614
| +11% | +$328K |
2013 Q2
39 quarters
|
|
|
EQRX
3036
DELISTED
EQRx, Inc. Common Stock
EQRX
| $3.21M | ﹤0.01% |
1,656,605
+67,145
| +4% | +$153K |
2022 Q2
3 quarters
|
|
3037
Caribou Biosciences
CRBU
$122M
| $3.2M | ﹤0.01% |
602,978
+2,881
| +0.5% | +$17.9K |
2021 Q3
6 quarters
|
|
3038
monday.com
MNDY
$3.56B
| $3.17M | ﹤0.01% |
+22,180
| New | +$3M |
2023 Q1
0 quarters
|
|
3039
CALL
Hecla Mining
HL
$11.5B
| $3.17M | ﹤0.01% |
+500,000
| New | +$2.87M |
2023 Q1
0 quarters
|
|
3040
Middlesex Water
MSEX
$997M
| $3.16M | ﹤0.01% |
40,455
+11,654
| +40% | +$940K |
2015 Q4
29 quarters
|
|
|
FSR
3041
DELISTED
Fisker Inc.
FSR
| $3.16M | ﹤0.01% |
514,769
-8,997
| -2% | -$62K |
2020 Q4
9 quarters
|
|
3042
Seer Inc
SEER
$121M
| $3.16M | ﹤0.01% |
817,399
+51,596
| +7% | +$237K |
2020 Q4
9 quarters
|
|
|
NSTG
3043
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.15M | ﹤0.01% |
318,289
+160,878
| +102% | +$1.59M |
2017 Q4
21 quarters
|
|
3044
Heritage Financial
HFWA
$1.13B
| $3.15M | ﹤0.01% |
147,167
-89,911
| -38% | -$2.43M |
2014 Q2
35 quarters
|
|
3045
Spectrum Brands
SPB
$1.76B
| $3.15M | ﹤0.01% |
47,509
-26,604
| -36% | -$1.68M |
2013 Q2
39 quarters
|
|
3046
Sturm, Ruger & Co
RGR
$697M
| $3.14M | ﹤0.01% |
54,687
+21,191
| +63% | +$1.18M |
2015 Q2
31 quarters
|
|
|
KYNB
3047
Kyntra Bio
KYNB
$24.1M
| $3.14M | ﹤0.01% |
6,732
-470
| -7% | -$249K |
2014 Q4
33 quarters
|
|
3048
Burford Capital
BUR
$795M
| $3.13M | ﹤0.01% |
283,380
-2,313,090
| -89% | -$19.2M |
2020 Q4
9 quarters
|
|
3049
Vanguard Morningstar Mega Cap ETF
MGC
$10.6B
| $3.13M | ﹤0.01% |
21,875
-319
| -1% | -$44.2K |
2018 Q2
19 quarters
|
|
3050
Shift4
FOUR
$3.04B
| $3.12M | ﹤0.01% |
41,155
-541,992
| -93% | -$34.9M |
2020 Q3
10 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.